These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Median Nerve Stimulation for Treatment of Tics: A 4-Week Open Trial with Ecological Momentary Assessment. Iverson AM, Arbuckle AL, Song DY, Bihun EC, Black KJ. J Clin Med; 2023 Mar 28; 12(7):. PubMed ID: 37048629 [Abstract] [Full Text] [Related]
23. Proof of Concept Study of an Oral Orthotic in Reducing Tic Severity in Tourette Syndrome. Bennett SM, Hindin JS, Mohatt J, Bauer C, Schild J, Falk A, Specht M, Woods D, Walkup J. Child Psychiatry Hum Dev; 2022 Oct 28; 53(5):953-963. PubMed ID: 33959852 [Abstract] [Full Text] [Related]
24. Embedded Human Closed-Loop Deep Brain Stimulation for Tourette Syndrome: A Nonrandomized Controlled Trial. Cagle JN, Okun MS, Cernera S, Eisinger RS, Opri E, Bowers D, Ward H, Foote KD, Gunduz A. JAMA Neurol; 2022 Oct 01; 79(10):1064-1068. PubMed ID: 36094652 [Abstract] [Full Text] [Related]
32. Improved Yale Total Tic Severity Score Due to Craniofacial Manipulation With an Oral Appliance. Hottel TL, Jack RL, Taynor E, Wells M, Hollis W. Compend Contin Educ Dent; 2019 Jan 01; 40(1):e6-e15. PubMed ID: 30601024 [Abstract] [Full Text] [Related]
33. Long-term clinical and cost-effectiveness of a therapist-supported online remote behavioural intervention for tics in children and adolescents: extended 12- and 18-month follow-up of a single-blind randomised controlled trial. Hollis C, Hall CL, Khan K, Jones R, Marston L, Le Novere M, Hunter R, Andrén P, Bennett SD, Brown BJ, Chamberlain LR, Davies EB, Evans A, Kouzoupi N, McKenzie C, Sanderson C, Heyman I, Kilgariff J, Glazebrook C, Mataix-Cols D, Serlachius E, Murray E, Murphy T. J Child Psychol Psychiatry; 2023 Jun 01; 64(6):941-951. PubMed ID: 36649686 [Abstract] [Full Text] [Related]
36. CANNA-TICS: Efficacy and safety of oral treatment with nabiximols in adults with chronic tic disorders - Results of a prospective, multicenter, randomized, double-blind, placebo controlled, phase IIIb superiority study. Müller-Vahl KR, Pisarenko A, Szejko N, Haas M, Fremer C, Jakubovski E, Musil R, Münchau A, Neuner I, Huys D, van Elst LT, Schröder C, Ringlstetter R, Koch A, Jenz EB, Großhennig A. Psychiatry Res; 2023 May 01; 323():115135. PubMed ID: 36878177 [Abstract] [Full Text] [Related]